General Pharmacology: The Vascular System
ReviewThe mechanisms of action of disease-modifying antirheumatic drugs: A review with emphasis on macrophage signal transduction and the induction of proinflammatory cytokines☆
References (288)
- et al.
A comparison of effects of sulfasalazine and its metabolites on the metabolism of endogenous vs. exogenous arachidonic acid
Immunopharmacology
(1988) - et al.
Raf meets Ras: completing the framework of a signal transduction pathway
Trends Biochem. Sci.
(1994) - et al.
Ethanol inhibits zymosan-stimulated eicosanoid production in mouse peritoneal macrophages
Biochim. Biophys. Acta
(1994) - et al.
Auranofin stimulates LTA hydropase and inhibits 5-lipoxygenase/LTA synthase activity of isolated human neutrophils
Biochem. Pharmac.
(1990) - et al.
Effect of d-penicillamine in vitro and in vivo on macrophage phagocytosis
Biochem. Pharmac.
(1980) - et al.
Diversity in function and regulation of MAP kinase pathways
Trends Biochem. Sci.
(1994) Effects of tenidap on intracellular signal transduction and the induction of proinflammatory cytokines (Review)
Gen. Pharmac.
(1996)- et al.
Auranofin inhibits the induction of interleukin 1 and tumor necrosis factor α mRNA in macrophages
Biochem. Pharmac.
(1995) - et al.
Differential effect of tenidap on the induction of proinflammatory cytokines in macrophages
Biochem. Pharmac.
(1996) - et al.
Epidermal growth factor enhances glomerular mesangial cell soluble phospholipase A2 activity
J. Biol. Chem.
(1990)
Inhibitory effect of TNFa antibodies on synovial cell interleukin-1 production in rheumatoid arthritis
Lancet
Regulation of Ras-mediated signalling: more than one way to skin a cat
Trends Biochem. Sci.
Parallel signal processing among mammalian MAPKs
Trends Biochem. Sci.
The gold complexes
Baillière's Clin. Rheumatol.
Modulation of mediator release from human basophils and pulmonary mast cells and macrophages by auranofin
Biochem. Pharmac.
Cytokine modulation as a medicinal chemistry target
Annu. Rep. Med. Chem.
MAPKs: new JNK expands the group
Trends Biochem. Sci.
The role of cytokines and their inhibitors in arthritis
Baillière's Clin. Rheumatol.
The effect of second-line antirheumatic drugs on interleukin-8 mRNA synthesis and protein secretion in human endothelial cells
Cytokines
Modalities for reducing interleukin 1 activity in disease
Trends Pharma. Sci.
Proteinkinase C-isoform triggers the formation of prostanoids and superoxide in liver macrophages
Biochim. Biophys. Res. Commun.
Correlation of plasma interleukin-1 levels with disease activity in rheumatoid arthritis
Lancet
Randomized double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor (cA2) versus placebo in rheumatoid arthritis
Lancet
Differential activation of phosphatidylinositol deacylation and a pathway via diphosphoinositide in macrophages responding to zymosan and ionophore A23187
J. Biol. Chem.
Chloroquin attenuates hemorrhagic shock-induced suppression of Kupffer cell antigen presentation and major histocompatibility complex class II antigen expression through blockade of tumor necrosis factor and prostaglandin release
Blood
Inhibition of epidermal growth factor binding to HeLa cells by auranofin
Biochem. Pharmacol.
Inhibition of protein kinase C activity by the antirheumatic drug auranofin
Biochem. Pharmac.
Macrophages as destructive cells in host defence
Inhibition of mitogen-induced response of human peripheral blood mononuclear cells by bucillamine, a new antirheumatic sulfhydryl drug
Rheumatol. Int.
Auranofin inactivates phosphofructokinase in human neutrophils, leading to depletion of intracellular ATP and inhibition of superoxide generation and locomotion
Mol. Pharmac.
Interleukin-l-mediated phospholipid breakdown and arachidonic acid release in human synovial cells
Arthritis Rheum.
Inhibition of the production and effects of interleukin-1 and tumor necrosis factor in rheumatoid arthritis
Arthritis Rheum
Neutrophil-activating peptide-11 interleukin-8, a novel cytokine that activates neutrophils
J. Clin. Invest.
Methotrexate in rheumatoid arthritis: an update
Drugs
Circulating concentrations and production of cytokines and soluble receptors in rheumatoid arthritis patients: effect of a single dose methotrexate
Br. J. Rheumatol.
Circulation soluble tumor necrosis factor receptors, interleukin 2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis: longitudinal evaluation during methotrexate and azathioprine therapy
Arthritis Rheum.
Lipopolysaccharide-induced cytokine production in human monocytes: role of tyrosine phosphorylation in transmembrane signal transduction
Eur. J. Biochem.
Monocyte superoxide generation in ankylosing spondylitis: effects of salazopyrin and metabolites
Rheumatol. Eur.
Phospholipase A2 activity of guinea-pig isolated perfused lungs: stimulation, and inhibition by anti-inflammatory steroids
Br. J. Pharmac.
Effects of Disease-Modifying Antirheumatic Drugs on Macrophage Signal Transduction and the Induction of Proinflammatory Cytokines
Antirheumatic gold compounds and penicillamine enhance protein kinase C-mediated activation of the arachidonate-mobilizing phospholipase A2 in mouse macrophages
J. Leukocyte Biol.
Antimalarial drugs inhibit phospholipase A2 activation and induction of interleukin 1 β and tumor necrosis factor α in macrophages: implications for their mechanism of action in rheumatoid arthritis
Team blue sees red
Nature
Tenidap: a novel cytokine-modulating antirheumatic drug for the treatment of rheumatoid arthritis
Scand. J. Rheumatol.
Cytokine expression in rheumatoid arthritis
Br. J. Rheumatol.
Enhanced expression of tumor necrosis factor receptor mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints
Eur. J. Immunol.
d-Penicillamine inhibition of interleukin-1 production: a possible mechanism for its effect on synovial collagen synthesis
Int. J. Tissue React.
Mechanism of action of methotrexate: experimental evidence that methotrexate blocks the binding of interleukin 1β to the interleukin 1 receptor on target cells
Eur. J. Clin. Chem. Clin. Biochem.
Dose-range and dose frequency study of human interleukin-l receptor antagonist in patients with rheumatoid arthritis
Arthritis Rheum.
Effects of D-penicillamine, levamisole and tiopronin on eicosanoid synthesis by rat gut tissue
Agents Actions
Cited by (112)
Emerging role of macrophages in non-infectious diseases: An update
2023, Biomedicine and PharmacotherapyA rare case of vasculitis in cystic fibrosis: A clinical case
2023, Respiratory Medicine Case ReportsAnkylosing spondylitis and mesenchymal stromal/stem cell therapy: a new therapeutic approach
2019, Biomedicine and PharmacotherapyCitation Excerpt :While methotrexate, by inhibiting the enzyme dihydrofolate reductase, is a purine metabolism inhibitor. Therefore, by increasing adenosine, its inhibitory effects are widely applied [59,60]. Also, DMARDs can influence the expression and function of ATP-binding cassette (ABC) proteins in the autoimmune diseases [61].
Correlation of cytokines, BDNF levels, and memory function in patients with opioid use disorder undergoing methadone maintenance treatment
2018, Drug and Alcohol DependenceCitation Excerpt :NSAIDs might also affect the responses of IL-2, IL-6, IL-8, and monocyte chemoattractant protein-1 (Lisboa et al., 2017). DMARDs inhibit the induction of cytokines in monocytes and macrophages (Bondeson, 1997) and interfere with IL-6 and TNF-α expression (Mangoni et al., 2017). Therefore, the current study excluded patients taking anti-inflammatory agents.
Isoimperatorin attenuates airway inflammation and mucus hypersecretion in an ovalbumin-induced murine model of asthma
2017, International ImmunopharmacologyTherapeutic effects of rosmarinic acid on airway responses in a murine model of asthma
2016, International Immunopharmacology
- ☆
Dr. Roger Sundler, of Lund University, Sweden, is thanked for valuable help and advice. Financial report from the Swedish Medical Research Council (MRC project no. 05410), the National League against Rheumatism (Stockholm), the Swedish Society for Medical Research (Stockholm), the Albert Påhlsson Foundation (Malmö), the Alfred Österlund Foundation (Malmö), the Börje Dahlin Foundation (Upplands-Väsby), the Greta and Johan Kock Foundations (Trelleborg), the King Gustaf V 80 Year Foundation (Stockholm) and the Research Funds of Malmö University Hospital and the Medical Faculty, Lund University, is gratefully acknowledged.